[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Pages 19597-19598]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9803]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 10, 2009, Penick 
Corporation, 33 Industrial Road, Pennsville, New Jersey 08070, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................   II
Codeine (9050).............................   II
Dihydrocodeine (9120)......................   II
Oxycodone (9143)...........................   II
Hydromorphone (9150).......................   II
Diphenoxylate (9170).......................   II
Ecgonine (9180)............................   II
Hydrocodone (9193).........................   II
Morphine (9300)............................   II

[[Page 19598]]

 
Oripavine (9330)...........................   II
Thebaine (9333)............................  II
Oxymorphone (9652).........................   II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
as bulk controlled substance intermediates for distribution to its 
customers for further manufacture or to manufacture pharmaceutical 
dosage forms.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 29, 2009.

    Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-9803 Filed 4-28-09; 8:45 am]
BILLING CODE 4410-09-P